Updated: January 3, 2026
Alternatives to Amoxicillin/Vonoprazan If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Always Talk to Your Doctor First
- Alternative 1: Bismuth Quadruple Therapy (BQT) — ACG Preferred First-Line
- Alternative 2: Voquezna Triple Pak (Vonoprazan + Amoxicillin + Clarithromycin)
- Alternative 3: Rifabutin Triple Therapy (Talicia)
- Alternative 4: Levofloxacin-Based Triple Therapy
- Comparing Your Options at a Glance
- What If You Have a Penicillin Allergy?
- The Bottom Line
Can't fill your Amoxicillin/Vonoprazan prescription? Explore FDA-approved H. pylori alternatives including bismuth quadruple therapy, Talicia, and more for 2026.
Amoxicillin/Vonoprazan (Voquezna Dual Pak) is one of the most effective treatments for H. pylori infection available in the U.S., but it isn't always accessible. Whether your pharmacy doesn't stock it, your insurance won't cover it without prior authorization, or the cost is too high, you need an alternative plan — and you need it quickly, because H. pylori shouldn't go untreated.
The good news: there are several FDA-approved and guideline-recommended alternatives that your doctor can prescribe. Here is a thorough breakdown of your options.
Always Talk to Your Doctor First
Before switching medications, contact your prescriber. The right alternative depends on your specific situation: any antibiotic allergies you have, whether you have heart disease or a history of clarithromycin use, your insurance coverage, local antibiotic resistance patterns, and cost. Don't start any H. pylori treatment without a prescription.
Alternative 1: Bismuth Quadruple Therapy (BQT) — ACG Preferred First-Line
The 2024 American College of Gastroenterology (ACG) guidelines name bismuth quadruple therapy as the preferred first-line treatment for H. pylori in treatment-naive patients when antibiotic susceptibility is unknown. This regimen includes:
- A proton pump inhibitor (e.g., omeprazole 20 mg twice daily)
- Bismuth subsalicylate (524 mg four times daily)
- Metronidazole (500 mg three to four times daily)
- Tetracycline (500 mg four times daily)
Duration: 14 days. Eradication rates: 85–90%. All four drugs are available as generics and typically cost $30–$80 total — a fraction of the cost of Voquezna Dual Pak. The main downside is complexity: four drugs, multiple daily doses.
Pylera is a combination capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline in a single pill, simplifying the regimen.
Alternative 2: Voquezna Triple Pak (Vonoprazan + Amoxicillin + Clarithromycin)
If you want to stay with a vonoprazan-based regimen but prefer the triple combination, Voquezna Triple Pak adds clarithromycin 500 mg twice daily to vonoprazan and amoxicillin. It is FDA-approved for H. pylori eradication in adults and uses the same co-package format as the Dual Pak.
The Triple Pak is suggested when clarithromycin susceptibility can be documented. It's not a suitable replacement if you have clarithromycin resistance or if you've had significant prior macrolide exposure. Cost is similar to the Dual Pak at $835–$1,000+ retail.
Alternative 3: Rifabutin Triple Therapy (Talicia)
Talicia is an FDA-approved combination pill containing omeprazole, amoxicillin, and rifabutin — taken three times daily for 14 days. Its key advantage: rifabutin resistance is extremely rare (less than 3%), making it an excellent option for patients who have failed other regimens.
The 2024 ACG guidelines list rifabutin triple therapy as an empiric alternative first-line regimen. Cost: $500–$800 retail. Manufacturer savings programs may be available.
Alternative 4: Levofloxacin-Based Triple Therapy
A PPI + amoxicillin + levofloxacin regimen given twice daily for 14 days has been used as a salvage therapy when first-line regimens fail. This combination uses generic drugs and typically costs $20–$60. However, levofloxacin resistance rates have been rising (around 38% in some U.S. surveys as of 2024), which limits its use as empiric therapy.
Comparing Your Options at a Glance
- Bismuth Quadruple Therapy: ACG preferred; generic; $30–$80; 85–90% eradication; complex dosing schedule
- Voquezna Triple Pak: FDA-approved; branded; $835–$1,000+; use when clarithromycin susceptibility confirmed
- Rifabutin Triple Therapy (Talicia): FDA-approved; branded; $500–$800; excellent for multidrug-resistant strains
- Levofloxacin Triple Therapy: Salvage therapy; generic; $20–$60; limited by rising fluoroquinolone resistance
What If You Have a Penicillin Allergy?
If you have a true penicillin allergy, Amoxicillin/Vonoprazan is not appropriate for you. Bismuth quadruple therapy (which doesn't contain penicillin) is the standard recommended alternative. Your doctor may also consider allergy testing to distinguish true penicillin allergy from a reaction to a different drug, since many patients who think they're allergic to penicillin actually aren't.
The Bottom Line
If you can't fill your Amoxicillin/Vonoprazan prescription, you have effective alternatives. Bismuth quadruple therapy is affordable and guideline-preferred. Talicia is excellent for drug-resistant cases. Talk to your doctor about which option fits your medical history and budget — and start treatment without unnecessary delay. Also see: Why Is Amoxicillin/Vonoprazan So Hard to Find?
Frequently Asked Questions
According to 2024 ACG guidelines, bismuth quadruple therapy (PPI + bismuth + metronidazole + tetracycline for 14 days) is the preferred first-line alternative. It achieves 85–90% eradication rates and costs $30–$80 as generics. Rifabutin triple therapy (Talicia) is another strong option, especially for drug-resistant infections.
Yes, with your doctor's guidance. Voquezna Triple Pak adds clarithromycin to the vonoprazan/amoxicillin combination and is FDA-approved for H. pylori. It's recommended when clarithromycin susceptibility is confirmed and is not appropriate if you have prior macrolide resistance or significant clarithromycin exposure.
There is no generic version of Voquezna Dual Pak. However, all the components of bismuth quadruple therapy (PPI, bismuth subsalicylate, metronidazole, tetracycline) are available as generics at very low cost, making it the most affordable alternative. Levofloxacin triple therapy is also generic and low-cost.
Bismuth quadruple therapy (PPI + bismuth + metronidazole + tetracycline) is the recommended regimen for penicillin-allergic patients. It does not contain amoxicillin. Discuss allergy history with your doctor, since many patients have a cross-reactivity risk that can be assessed through formal allergy testing.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Amoxicillin/Vonoprazan also looked for:
More about Amoxicillin/Vonoprazan
35,948 have already found their meds with Medfinder.
Start your search today.





